Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/22/2014WO2014077354A1 Long non-coding rna used for anticancer therapy
05/22/2014WO2014077289A1 Anticancer agent
05/22/2014WO2014077285A1 Pyridine derivative
05/22/2014WO2014077244A1 Transdermal absorption sheet, and manufacturing method for same
05/22/2014WO2014077242A1 Method for manufacturing transdermal-absorption sheet
05/22/2014WO2014077235A1 2-pyridone compound
05/22/2014WO2014077224A1 Antimicrobial agent
05/22/2014WO2014077135A1 Blood acetaldehyde level-reducing agent
05/22/2014WO2014077062A1 Transparent gel-like skin-sterilizing agent
05/22/2014WO2014076965A1 1-indane derivative having anti-protozoal activity
05/22/2014WO2014076712A2 Lurasidone hydrochloride solid dispersion
05/22/2014WO2014076703A1 Methods and compositions for treating cancer
05/22/2014WO2014076680A1 Solid dosage form comprising micronized cytisine
05/22/2014WO2014076643A1 Compound particularly for treating depression and anxiety
05/22/2014WO2014076642A1 Topical composition for the transepidermal or transdermal delivery of paracetamol
05/22/2014WO2014076639A1 Enemas
05/22/2014WO2014076638A1 Broad-spectrum anti-parasitic composition consisting of nitazoxanide, probiotics and prebiotics
05/22/2014WO2014076632A1 A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker
05/22/2014WO2014076569A2 Controlled release topical testosterone formulations and methods
05/22/2014WO2014076484A1 Kinase inhibitors
05/22/2014WO2014076453A1 Adrenergic agonists for use in treating liver damage
05/22/2014WO2014076415A1 Use of polysaccharides for the intestinal well-being of nursing infants and/or infants
05/22/2014WO2014076338A1 Use of a photosensitive agent capable of producing reactive oxygen species in the production of a drug for the photodynamic therapy of a disease related to stem cells, in vitro use, and pharmaceutical composition
05/22/2014WO2014076312A1 Sulforaphane for treating or reducing insulin resistance of the liver
05/22/2014WO2014076261A1 Sulphated polysaccharide composition
05/22/2014WO2014076237A1 Triazolopyrazine
05/22/2014WO2014076235A1 Modulators of intracellular chloride concentration for treating fragile x syndrome
05/22/2014WO2014076221A1 Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
05/22/2014WO2014076203A1 Medicinal lozenge based on ibuprofen sodium dihydrate
05/22/2014WO2014076170A1 Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as|sigma receptors ligands
05/22/2014WO2014076162A1 Aminoimidazopyridazines
05/22/2014WO2014076150A1 Amphoteric polyamidoamines in the treatment of malaria
05/22/2014WO2014076146A1 Triazolopyridazine
05/22/2014WO2014076136A1 Bpo wash emulsion composition
05/22/2014WO2014076135A1 Bpo wash gel composition
05/22/2014WO2014076117A1 Orodispersible film compositions
05/22/2014WO2014076111A1 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
05/22/2014WO2014076104A1 Inhibitors of bruton's tyrosine kinase
05/22/2014WO2014076092A1 A proton pump inhibitor for use in a method of treating dermatological diseases in canine
05/22/2014WO2014076091A1 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
05/22/2014WO2014076038A1 Novel acetamide derivatives as trp channel antagonists
05/22/2014WO2014076028A1 4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
05/22/2014WO2014076021A1 Imidazopyridine derivatives
05/22/2014WO2014075935A1 Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient
05/22/2014WO2014075754A1 3-aminocyclopentane carboxamide derivatives
05/22/2014WO2014075692A1 Dispersible tablet
05/22/2014WO2014075691A1 Oxiran amines
05/22/2014WO2014075680A1 Crystalline 3-o-fucosyllactose
05/22/2014WO2014075676A1 Amines from trigonella foemum - graecum
05/22/2014WO2014075636A1 Certain dipeptidyl peptidase inhibitors
05/22/2014WO2014075618A1 Heterocyclic ring-containing 5-hydroxy indole derivative and use thereof
05/22/2014WO2014075583A1 Stable oral solid drug composition of abiraterone and preparation method therefor
05/22/2014WO2014075580A1 Use of aurintricarboxylic acid in preparation of drug targeting chemokine receptor
05/22/2014WO2014075575A1 Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
05/22/2014WO2014075574A1 A method of using binuclear gold(i) compounds for cancer treatment
05/22/2014WO2014075554A1 Pharmaceutical composition containing sirolimus esterification and preparation method thereof
05/22/2014WO2014075394A1 Novel gold(iii) complexes containing n-heterocyclic carbene ligand, synthesis, and their applications in cancer treatment and thiol detection
05/22/2014WO2014075393A1 Purine inhibitors of human phosphatidylinositol 3-kinase delta
05/22/2014WO2014075392A1 Purine inhibitors of human phosphatidylinositol 3-kinase delta
05/22/2014WO2014075391A1 Platinum compound of malonic acid derivative having leaving group containing amino or alkylamino
05/22/2014WO2014075387A1 Diaryl hydantoin derivative, and preparation method, pharmaceutical composition and use thereof
05/22/2014WO2014075318A1 Pyrimidine compounds and use thereof
05/22/2014WO2014075317A1 Certain dipeptidyl peptidase inhibitors
05/22/2014WO2014075309A1 Use and preparation method of berberine compounds
05/22/2014WO2014075308A1 Pharmaceutical composition for treatment of cancers, lyophilized preparation for injection of the pharmaceutical composition, preparation method for same, and applications thereof
05/22/2014WO2014075207A1 Tincture for treating alopecia
05/22/2014WO2014075203A1 Nanoparticles with biodegradable and biocompatible polymer plga, loaded with the drug for human use pentoxifylline
05/22/2014WO2014075187A1 Spermidine/spermine n1-acetyltransferase substrates as anti-cancer drug compounds
05/22/2014WO2014075168A1 Pyrazolopyrimidine compounds
05/22/2014WO2014075155A1 Pharmaceutical combination containing an analgesic agent and an antispasmodic agent
05/22/2014WO2014075146A1 Macrocyclic compounds and uses thereof
05/22/2014WO2014075135A1 Transmucosal delivery of tocotrienol
05/22/2014WO2014075124A1 Methods and compositions for the treatment and/or prevention of bowel disorders
05/22/2014WO2014052836A3 Methods and compositions for treating infection
05/22/2014WO2014052415A3 Measurement of brain cdp-diacylglycerol synthase 1 enzyme and uses thereof
05/22/2014WO2014051654A3 Bicyclic oxa-lactam kinase inhibitors
05/22/2014WO2014051318A3 Short interference rna gene delivery system for systemic circulation
05/22/2014WO2014049612A3 Processes and polymorphs of 5-[4-[4-(5-cyano-1h-indol-3-yl) butyl]-1-piperazinyl]-2-benzofuran carboxamide and its salts
05/22/2014WO2014046474A3 Composition comprising metformin as active ingredient for preventing or treating inflammatory bowel disease
05/22/2014WO2014041487A3 Enzalutamide polymorphic forms and its preparation
05/22/2014WO2014040052A3 Glycyrrhetinic acid derivatives with anti-inflammatory activity
05/22/2014WO2014031936A3 Heterocyclic modulators of hif activity for treatment of disease
05/22/2014WO2014031933A3 Heterocyclic modulators of hif activity for treatment of disease
05/22/2014WO2014031928A3 Heterocyclic modulators of hif activity for treatment of disease
05/22/2014WO2013159094A3 Improved processes for the preparation of 1-aryl-5-alkyl pyrazole compounds
05/22/2014WO2013102919A8 Polymorphic forms of ivabradine hydrochloride
05/22/2014WO2013064326A3 Arjunolic acid for increasing the production of sebum
05/22/2014WO2013061091A8 Cystic fibrosis treatment
05/22/2014WO2013059278A3 Hepatitis c virus inhibitors
05/22/2014WO2013039861A3 Engineered nucleic acids and methods of use thereof
05/22/2014WO2013032797A3 Oxetane 3,3-dicarboxamide compounds and methods of making and using same
05/22/2014WO2013010089A8 Inhibitors of bacterial type iii secretion system
05/22/2014WO2012097281A3 Injectable filler for podiatric and orthopedic uses
05/22/2014US20140142549 Urgency Therapy with Neuromodulation and C-Afferent Nerve Desensitization
05/22/2014US20140142195 Methods for the alleviation of sexual dysfunction in women
05/22/2014US20140142193 Stabilized Compositions Of Alkylating Agents And Methods Of Using Same
05/22/2014US20140142192 Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators
05/22/2014US20140142191 Production of thermoreversible hydrogels for therapeutic applications
05/22/2014US20140142188 Prostaglandin compositions and methods for the treatment of vasospasm
05/22/2014US20140142187 Pharmaceutical Suspension Composition
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 7860